CDK5 inhibitors (University of Nebraska Medical Center)

N/A

Report date: 2025/03/19 08:58:33
NME

Base Information

Drug NameCDK5 inhibitors (University of Nebraska Medical Center)
Drug Alias Namecyclin-dependent kinase-5 inhibitors (University of Nebraska Medical Center)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 5 inhibitors
TargetsCyclin-dependent kinase 5
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Nebraska Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Nebraska Medical Center
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A